Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Sales (2016 - 2025)

CorMedix's Return on Sales history spans 14 years, with the latest figure at 0.09% for Q4 2025.

  • For Q4 2025, Return on Sales fell 49.0% year-over-year to 0.09%; the TTM value through Dec 2025 reached 0.44%, up 88.0%, while the annual FY2025 figure was 0.44%, 85.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.09% at CorMedix, down from 1.04% in the prior quarter.
  • Across five years, Return on Sales topped out at 2157.76% in Q2 2024 and bottomed at 1925.28% in Q3 2023.
  • The 5-year median for Return on Sales is 81.71% (2021), against an average of 107.54%.
  • The largest annual shift saw Return on Sales skyrocketed 350729bps in 2024 before it plummeted -215725bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 171.42% in 2021, then plummeted by -61bps to 276.56% in 2022, then plummeted by -596bps to 1925.28% in 2023, then skyrocketed by 100bps to 0.4% in 2024, then plummeted by -123bps to 0.09% in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Return on Sales are 0.09% (Q4 2025), 1.04% (Q3 2025), and 0.51% (Q2 2025).